GLP1 Receptor Agonism Alters Growth and Therapeutic Response in Prostate Cancer

By
Jamie Kang
-
0
47
In prostate cancer models, semaglutide decreased cell proliferation, glycolytic function, and phospho-kinase-mediated signaling.
[Endocrine-Related Cancer]
Abstract